Top

Current Sexual Health Reports

Published in:

01-09-2019 | Erectile Dysfunction | Male and Female Surgical Interventions (C Carson and M Khera, Section Editors)

Minimizing Sexual Dysfunction in BPH Surgery

Authors: Joon Yau Leong, Amir S. Patel, Ranjith Ramasamy

Published in: Current Sexual Health Reports | Issue 3/2019

Abstract

Purpose of Review

To review the prevalence and risks of sexual dysfunction associated with current treatment options for benign prostatic hyperplasia and to characterize techniques and methods to manage postoperative sexual dysfunction-related side effects.

Recent Findings

Current surgical therapies available for the treatment of benign prostatic hyperplasia are associated with a substantial risk of both ejaculatory and erectile function. However, many of the novel minimally invasive treatment alternatives have demonstrated the ability to preserve postoperative sexual function to a better degree, all while providing significant relief of lower urinary tract symptoms in an equally safe and efficacious manner.

Summary

Benign prostatic hyperplasia remains a highly prevalent disease among the aging population. While surgical treatments are often necessary to relieve bothersome urinary symptoms, these procedures are associated with an increased risk of sexual dysfunction. As such, there has been an increased interest in the development of minimally invasive therapies, such as the UroLift®, Rezum®, and Aquablation®, with the hopes of achieving similar symptomatic relief while maintaining sexual function. Aside from reporting lower rates of sexual dysfunction, these procedures have also demonstrated comparable safety, durability, and efficacy to current gold standard therapies. Some procedures can even be performed in an outpatient setting, avoiding the need for general anesthesia altogether. Overall, an individualized, shared decision-making approach is necessary to determine the ideal treatment option for each patient.

Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7(Suppl 9):S3–S14.PubMedPubMedCentral

Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.CrossRefPubMed

•• Borchert A, Leavitt DA. A review of male sexual health and dysfunction following surgical treatment for benign prostatic hyperplasia and lower urinary tract symptoms. Curr Urol Rep. 2018;19(8):66. https://doi.org/10.1007/s11934-018-0813-0. This comprehensive review summarizes post-procedural sexual dysfunction after utility of current treatment modalities available for BPH. CrossRefPubMed

Calais Da Silva F, Marquis P, Deschaseaux P, Gineste JL, Cauquil J, Patrick DL. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. Eur Urol. 1997;31(3):272–80.CrossRefPubMed

Alloussi SH, Lang C, Eichel R, Alloussi S. Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique. J Endourol. 2014;28(1):84–9. https://doi.org/10.1089/end.2013.0093.CrossRefPubMed

Kim M, Song SH, Ku JH, Kim HJ, Paick JS. Pilot study of the clinical efficacy of ejaculatory hood sparing technique for ejaculation preservation in Holmium laser enucleation of the prostate. Int J Impot Res. 2015;27(1):20–4. https://doi.org/10.1038/ijir.2014.22.CrossRefPubMed

Talab SS, Santiago-Lastra YA, Bachmann A, Choi BB, Muir GH, Woo HH, et al. V403 the impact of ejaculation-preserving photo-selective vaporization of the prostate (EP-PVP) on lower urinary tract symptoms and ejaculatory function: results of a multicenter study. J Urol. 2013;189(4S):e164. https://doi.org/10.1016/j.juro.2013.02.1792.CrossRef

Wang P, Xia D, Ye S, Kong D, Qin J, Jing T, et al. Robotic-assisted urethra-sparing simple prostatectomy via an extraperitoneal approach. Urology. 2018;119:85–90. https://doi.org/10.1016/j.urology.2018.06.005.CrossRefPubMed

•• Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802–13. This prospective, randomized controlled trial is the landmark study evaluating the efficacy of UroLift of up to 5 years. PubMed

10.

McVary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2018;111:1–9. https://doi.org/10.1016/j.urology.2017.10.023.CrossRefPubMed

11.

Kasivisvanathan V, Hussain M. Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomes. Can J Urol. 2018;25(3):9317–22.PubMed

12.

Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115–22. https://doi.org/10.1016/j.jvir.2016.04.001.CrossRefPubMed

13.

Elhilali MM, Pommerville P, Yocum RC, Merchant R, Roehrborn CG, Denmeade SR. Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia. J Urol. 2013;189(4):1421–6. https://doi.org/10.1016/j.juro.2012.11.003.CrossRefPubMed

14.

Porpiglia F, Fiori C, Bertolo R, Giordano A, Checcucci E, Garrou D, et al. 3-year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction. BJU Int. 2018;122(1):106–12. https://doi.org/10.1111/bju.14141.CrossRefPubMed

15.

Fan Y-H, Lin A, Huang E, Chen K-K. Health care-seeking behavior in benign prostatic hyperplasia patients. Urol Sci. 2017;28(3):169–73.CrossRef

16.

Catania JA, Oakley LP, Rosen R, Pollack LM. Effects of interview mode on assessments of erectile and ejaculatory dysfunction among men with benign prostatic hyperplasia (BPH). J Sex Res. 2013;50(6):524–36. https://doi.org/10.1080/00224499.2012.666815.CrossRefPubMed

17.

Cornell LF, Mussallem DM, Gibson TC, Diehl NN, Bagaria SP, McLaughlin SA. Trends in sexual function after breast cancer surgery. Ann Surg Oncol. 2017;24(9):2526–38. https://doi.org/10.1245/s10434-017-5894-3.CrossRefPubMed

18.

Gil-Vernet JM, Alvarez-Vijande R, Gil-Vernet A. Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol. 1994;73(4):442–8.CrossRefPubMed

19.

Bruyère F. The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep. 2011;12(4):261–4. https://doi.org/10.1007/s11934-011-0199-8.CrossRefPubMed

20.

Pavone C, Abbadessa D, Scaduto G, Caruana G, Scalici Gesolfo C, Fontana D, et al. Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Arch Ital Urol Androl. 2015;87(1):8–13. https://doi.org/10.4081/aiua.2015.1.8.CrossRefPubMed

21.

Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, Strebel RT. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol. 2007;52(2):510–5. https://doi.org/10.1016/j.eururo.2007.01.088.CrossRefPubMed

22.

Chung A, Woo HH. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered? Curr Opin Urol. 2016;26(1):42–8. https://doi.org/10.1097/MOU.0000000000000247.CrossRefPubMed

23.

Becher EF, McVary KT. Surgical procedures for BPH/LUTS: impact on male sexual health. Sex Med Rev. 2014;2(1):47–55. https://doi.org/10.1002/smrj.20.CrossRefPubMed

24.

Bruyère F, Puichaud A, Pereira H, Faivre d'Arcier B, Rouanet A, Floc'h AP, et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol. 2010;58(2):207–11. https://doi.org/10.1016/j.eururo.2010.04.027.CrossRefPubMed

25.

Coursey JW, Morey AF, McAninch JW, Summerton DJ, Secrest C, White P, et al. Erectile function after anterior urethroplasty. J Urol. 2001;166(6):2273–6.CrossRefPubMed

26.

Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018;200(3):612–9. https://doi.org/10.1016/j.juro.2018.05.048.CrossRefPubMed

27.

Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. 1989. J Urol. 2002;167(2 Pt 2):999–1003 discussion 4.CrossRefPubMed

28.

• Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: time for a bespoke approach? Int J Urol. 2016;23(1):22–35. https://doi.org/10.1111/iju.12866. This review examines the effect of current surgical therapies and minimally invasive procedures for BPH on ejaculatory function. CrossRefPubMed

29.

Donovan JL, Peters TJ, Neal DE, Brookes ST, Gujral S, Chacko KN, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the CLasP study. J Urol. 2000;164(1):65–70.CrossRefPubMed

30.

Taher A. Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors. World J Urol. 2004;22(6):457–60. https://doi.org/10.1007/s00345-004-0449-1.CrossRefPubMed

31.

Møller-Nielsen C, Lundhus E, Møller-Madsen B, Nørgaard JP, Simonsen OH, Hansen SL, et al. Sexual life following ‘minimal’ and ‘total’ transurethral prostatic resection. Urol Int. 1985;40(1):3–4. https://doi.org/10.1159/000281022.CrossRefPubMed

32.

Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, et al. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013;112(1):109–20. https://doi.org/10.1111/j.1464-410X.2012.11662.x.CrossRefPubMed

33.

Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int. 2010;106(9):1339–43. https://doi.org/10.1111/j.1464-410X.2010.09401.x.CrossRefPubMed

34.

El-Assmy A, ElShal AM, Mekkawy R, El-Kappany H, Ibrahiem EHI. Erectile and ejaculatory functions changes following bipolar versus monopolar transurethral resection of the prostate: a prospective randomized study. Int Urol Nephrol. 2018;50(9):1569–76. https://doi.org/10.1007/s11255-018-1950-6.CrossRefPubMed

35.

• Frieben RW, Lin HC, Hinh PP, Berardinelli F, Canfield SE, Wang R. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl. 2010;12(4):500–8. https://doi.org/10.1038/aja.2010.33 This systematic review of randomized controlled trials and cohort studies report the impact of male sexual function of minimally invasive surgeries when compared to TURP. CrossRefPubMedPubMedCentral

36.

Keehn A, Fram E, Garg M, Maria P. UroLift in place of fiducial markers for patients with benign prostatic hyperplasia undergoing external beam radiation therapy. Urology. 2017;104:230–4. https://doi.org/10.1016/j.urology.2016.11.029.CrossRefPubMed

37.

Mock S, Leapman M, Stock RG, Hall SJ, Stone NN. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters. J Urol. 2013;190(5):1805–10. https://doi.org/10.1016/j.juro.2013.05.010.CrossRefPubMed

38.

Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998;12(5):457–9. https://doi.org/10.1089/end.1998.12.457.CrossRefPubMed

39.

Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53(1):160–6. https://doi.org/10.1016/j.eururo.2007.08.036.CrossRefPubMed

40.

Meng F, Gao B, Fu Q, Chen J, Liu Y, Shi B, et al. Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl. 2007;28(2):259–61. https://doi.org/10.2164/jandrol.106.000372.CrossRefPubMed

41.

Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006;175(5):1817–21. https://doi.org/10.1016/S0022-5347(05)00983-3.CrossRefPubMed

42.

Zong HT, Peng XX, Yang CC, Zhang Y. The impact of transurethral procedures for benign prostate hyperplasia on male sexual function: a meta-analysis. J Androl. 2012;33(3):427–34. https://doi.org/10.2164/jandrol.111.013490.CrossRefPubMed

43.

• DeLay KJ, Nutt M, McVary KT. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms. Transl Androl Urol. 2016;5(4):450–9. https://doi.org/10.21037/tau.2016.06.06. This review examines the effect of current surgical therapies and minimally invasive procedures for BPH on ejaculatory function. CrossRefPubMedPubMedCentral

44.

Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol. 2014;65(5):931–42. https://doi.org/10.1016/j.eururo.2013.10.040.CrossRefPubMed

45.

Thomas JA, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69(1):94–102. https://doi.org/10.1016/j.eururo.2015.07.054.CrossRefPubMed

46.

Spaliviero M, Strom KH, Gu X, Araki M, Culkin DJ, Wong C. Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function? J Endourol. 2010;24(12):2051–7. https://doi.org/10.1089/end.2010.0296.CrossRefPubMed

47.

Elshal AM, Elmansy HM, Elkoushy MA, Elhilali MM. Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology. 2012;80(5):1098–104. https://doi.org/10.1016/j.urology.2012.08.001.CrossRefPubMed

48.

Kavoussi PK, Hermans MR. Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med. 2008;5(11):2669–71. https://doi.org/10.1111/j.1743-6109.2008.00978.x.CrossRefPubMed

49.

Li Z, Chen P, Wang J, Mao Q, Xiang H, Wang X, et al. The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: a systematic review and network meta-analysis. Medicine (Baltimore). 2016;95(24):e3862. https://doi.org/10.1097/MD.0000000000003862.CrossRef

50.

Ponholzer A, Madersbacher S. Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment. Int J Impot Res. 2007;19(6):544–50. https://doi.org/10.1038/sj.ijir.3901578.CrossRefPubMed

51.

Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol. 1998;159(5):1588–93; discussion 93-4. https://doi.org/10.1097/00005392-199805000-00048.CrossRefPubMed

52.

Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol. 1997;79(2):181–5.CrossRefPubMed

53.

Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol. 2003;17(2):103–7. https://doi.org/10.1089/08927790360587432.CrossRefPubMed

54.

Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004;171(6 Pt 1):2336–40.CrossRefPubMed

55.

• Herberts M, Butcher M, Köhler T. The effect of LUTS/BPH and treatments on ejaculatory function. Curr Urol Rep. 2016;17(7):48. https://doi.org/10.1007/s11934-016-0604-4. This review examines the effect of current surgical therapies and minimally invasive procedures for BPH on ejaculatory function. CrossRefPubMed

56.

Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, et al. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014;113(4):615–22. https://doi.org/10.1111/bju.12540.CrossRefPubMed

57.

Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79(1):5–11. https://doi.org/10.1016/j.urology.2011.10.021.CrossRefPubMed

58.

Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012;9(2):568–75. https://doi.org/10.1111/j.1743-6109.2011.02568.x.CrossRefPubMed

59.

Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014;21(1):7094–101.PubMed

60.

Roehrborn CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin North Am. 2016;43(3):357–69. https://doi.org/10.1016/j.ucl.2016.04.008.CrossRefPubMed

61.

Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015;22(3):7772–82.PubMed

62.

Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study. J Urol. 2013;190(6):2161–7. https://doi.org/10.1016/j.juro.2013.05.116.CrossRefPubMed

63.

McVary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014;11(1):279–87. https://doi.org/10.1111/jsm.12333.CrossRefPubMed

64.

Sønksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68(4):643–52. https://doi.org/10.1016/j.eururo.2015.04.024.CrossRefPubMed

65.

Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159–68. https://doi.org/10.2147/RRU.S143679.CrossRefPubMedPubMedCentral

66.

Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Efficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2015;86(5):1042–7. https://doi.org/10.1016/j.urology.2015.05.046.CrossRefPubMed

67.

•• McVary KT, Rogers T, Roehrborn CG. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019. https://doi.org/10.1016/j.urology.2018.12.041. This prospective, randomized controlled study is the landmark study evaluating the efficacy of Rezum of up to 4 years.

68.

McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529–38. https://doi.org/10.1016/j.juro.2015.10.181.CrossRefPubMed

69.

McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med. 2016;13(6):924–33. https://doi.org/10.1016/j.jsxm.2016.03.372.CrossRefPubMed

70.

Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016;8:207–16. https://doi.org/10.2147/RRU.S119596.CrossRefPubMedPubMedCentral

71.

Mollengarden D, Goldberg K, Wong D, Roehrborn C. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis. 2018;21(3):379–85. https://doi.org/10.1038/s41391-017-0022-9.CrossRefPubMed

72.

Roehrborn CG, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 2017;197(6):1507–16. https://doi.org/10.1016/j.juro.2016.12.045.CrossRefPubMed

73.

MacRae C, Gilling P. How I do it: aquablation of the prostate using the AQUABEAM system. Can J Urol. 2016;23(6):8590–3.PubMed

74.

Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 2016;117(6):923–9. https://doi.org/10.1111/bju.13358.CrossRefPubMed

75.

• Gilling P, Anderson P, Tan A. Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol. 2017;197(6):1565–72. https://doi.org/10.1016/j.juro.2017.01.056 This prospective single arm study aimed to assess the safety and efficacy of aquablation. CrossRefPubMed

76.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: a double-blind, randomized, controlled trial of aquablation. J Urol. 2018;199(5):1252–61. https://doi.org/10.1016/j.juro.2017.12.065.CrossRefPubMed

77.

• Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Randomized controlled trial of aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia: one-year outcomes. Urology. 2019;125:169–73. https://doi.org/10.1016/j.urology.2018.12.002. This study reports the most recent 1 year outcomes comparing the safety and efficacy of aquablation to TURP. CrossRefPubMed

78.

Kurbatov D, Russo GI, Lepetukhin A, Dubsky S, Sitkin I, Morgia G, et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology. 2014;84(2):400–4. https://doi.org/10.1016/j.urology.2014.04.028.CrossRefPubMed

79.

Li Q, Duan F, Wang MQ, Zhang GD, Yuan K. Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results. Chin Med J. 2015;128(15):2072–7. https://doi.org/10.4103/0366-6999.161370.CrossRefPubMedPubMedCentral

80.

Wang MQ, Guo LP, Zhang GD, Yuan K, Li K, Duan F, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol. 2015;15:33. https://doi.org/10.1186/s12894-015-0026-5.CrossRefPubMedPubMedCentral

81.

Isaacson AJ, Raynor MC, Yu H, Burke CT. Prostatic artery embolization using embosphere microspheres for prostates measuring 80-150 cm(3): early results from a US trial. J Vasc Interv Radiol. 2016;27(5):709–14. https://doi.org/10.1016/j.jvir.2016.01.146.CrossRefPubMed

82.

Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol. 2015;26(12):1832–8. https://doi.org/10.1016/j.jvir.2015.08.018.CrossRefPubMed

83.

Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation. Int J Urol. 2015;22(8):766–72. https://doi.org/10.1111/iju.12797.CrossRefPubMed

84.

Pisco J, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms. J Vasc Interv Radiol. 2016;27(5):700–8. https://doi.org/10.1016/j.jvir.2016.01.138.CrossRefPubMed

85.

Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int. 2016;117(1):155–64. https://doi.org/10.1111/bju.13147.CrossRefPubMed

86.

Wang XY, Zong HT, Zhang Y. Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Clin Interv Aging. 2016;11:1609–22. https://doi.org/10.2147/CIA.S119241.CrossRefPubMedPubMedCentral

87.

Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://doi.org/10.1111/bju.14249.CrossRefPubMed

88.

Pham H, Sharma P. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy. Can J Urol. 2018;25(2):9228–37.PubMed

89.

Bowen DK, Butcher MJ, Botchway A, McVary KT. Counseling on sexual side effects from TURP. Can J Urol. 2015;22(6):8063–8.PubMed

90.

Albaugh JA, Sufrin N, Lapin BR, Petkewicz J, Tenfelde S. Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners. BMC Urol. 2017;17(1):45. https://doi.org/10.1186/s12894-017-0231-5.CrossRefPubMedPubMedCentral

91.

Patel RM, Bariol S. National trends in surgical therapy for benign prostatic hyperplasia in Australia. ANZ J Surg. 2019;89(4):345–9. https://doi.org/10.1111/ans.15016.CrossRefPubMed

92.

Malaeb BS, Yu X, McBean AM, Elliott SP. National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008). Urology. 2012;79(5):1111–6. https://doi.org/10.1016/j.urology.2011.11.084.CrossRefPubMedPubMedCentral

Title: Minimizing Sexual Dysfunction in BPH Surgery
Authors: Joon Yau Leong
Amir S. Patel
Ranjith Ramasamy
Publication date: 01-09-2019
Publisher: Springer US
Keywords: Erectile Dysfunction
Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Transurethral Prostate Resection
Published in: Current Sexual Health Reports / Issue 3/2019
Print ISSN: 1548-3584
Electronic ISSN: 1548-3592
DOI: https://doi.org/10.1007/s11930-019-00210-1

At a glance: The STEP trials

Springer Medicine

Minimizing Sexual Dysfunction in BPH Surgery

Abstract

Purpose of Review

Recent Findings

Summary

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2019

Update on Sexual Dysfunction Associated with Psychotropic Medications and Its Treatment

A Review of Female Genital Cutting (FGC) in the Dawoodi Bohra Community:

Exploration of Ion Channels in the Clitoris: a Review

“A Review of Female Genital Cutting in the Dawoodi Bohra Community: Part 3—the Historical, Anthropological and Religious Underpinnings of FGC in the Dawoodi Bohras”

Plant-Derived Supplements for Sexual Health and Problems: Part 1—Trends over the Past Decade

Antidepressants and Sexual Dysfunctions: a Translational Perspective